{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T15:00:14Z","timestamp":1763564414383,"version":"3.38.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007606","name":"Aarhus University Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007606","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>\n            <jats:italic>Background &amp; aims<\/jats:italic>: Hepatic encephalopathy (HE), one of the most serious prognostic factors for mortality in alcohol-related cirrhosis (ALD cirrhosis), is not recorded in Danish healthcare registries. However, treatment of HE with lactulose, the universal first-line treatment, can be identified through data on filled prescriptions. This study aimed to investigate if lactulose can be used as a surrogate marker of HE. <jats:italic>Methods<\/jats:italic>: We used Danish healthcare registries to establish a cohort of patients with ALD cirrhosis diagnosed in 2000\u20132018. Lactulose users were identified using data on filled prescriptions. We computed the prevalence and cumulative incidence of lactulose use, and then matched lactulose users with cohort members who were not using lactulose. This matched dataset was used to identify predictors of lactulose initiation, and to examine the association between lactulose use and all-cause mortality. <jats:italic>Results<\/jats:italic>: We included 23,089 patients, among whom we identified 4,789 first-time lactulose users. The prevalence of lactulose usage rose to 11% within the first 6 months after ALD diagnosis and reached 19% 5 years after inclusion. The 1-year cumulative incidence of lactulose use was 31%, and predictors of initiating lactulose use were history of severe liver disease (ascites, portal hypertension, spontaneous bacterial peritonitis or gastrointestinal bleeding) or hepatocellular carcinoma. Lactulose use was associated with higher mortality (adjusted hazard ratio 1.61 [95% confidence interval 1.53; 1.69]). <jats:italic>Conclusions<\/jats:italic>: Lactulose is used by 10\u201320% of patients with ALD cirrhosis, primarily those with severe cirrhosis, and lactulose users have a markedly higher mortality than nonusers. We conclude that lactulose use can be used to estimate the prevalence of HE and to reduce confounding from HE, but it should not be used as a surrogate for HE in studies with HE as an outcome.<\/jats:p>","DOI":"10.1007\/s11011-025-01533-w","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T07:58:45Z","timestamp":1737187125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lactulose use among patients with alcohol-related liver cirrhosis as a surrogate marker of hepatic encephalopathy: prevalence and association with mortality - a Danish nationwide cohort study"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9363-3495","authenticated-orcid":false,"given":"Emma Celia","family":"Herting","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5137-7268","authenticated-orcid":false,"given":"Morten Daniel","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6641-1430","authenticated-orcid":false,"given":"Peter","family":"Jepsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"issue":"6908","key":"1533_CR1","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1136\/bmj.307.6908.846","volume":"307","author":"PH Beardon","year":"1993","unstructured":"Beardon PH, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM (1993) Primary non-compliance with prescribed medication in primary care. BMJ 307(6908):846\u2013848","journal-title":"BMJ"},{"issue":"6","key":"1533_CR2","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3109\/00365521.2012.661759","volume":"47","author":"A Dam Fialla","year":"2012","unstructured":"Dam Fialla A, Schaffalitzky de Muckadell OB, Touborg Lassen A (2012) Incidence, etiology and mortality of cirrhosis: a population-based cohort study. Scand J Gastroenterol 47(6):702\u2013709","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"1533_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","volume":"106","author":"K Furu","year":"2010","unstructured":"Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, S\u00f8rensen HT (2010) The nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 106(2):86\u201394","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"10","key":"1533_CR4","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1111\/jgh.14635","volume":"34","author":"T Hanai","year":"2019","unstructured":"Hanai T, Shiraki M, Watanabe S, Imai K, Suetsugu A, Takai K, Moriwaki H, Shimizu M (2019) Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: a propensity score-matching analysis. J Gastroenterol Hepatol 34(10):1809\u20131816","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"1533_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-022-00366-6","volume":"8","author":"D H\u00e4ussinger","year":"2022","unstructured":"H\u00e4ussinger D, Dhiman RK, Felipo V, G\u00f6rg B, Jalan R, Kircheis G, Merli M, Montagnese S, Romero-Gomez M, Schnitzler A, Taylor-Robinson SD, Vilstrup H (2022) Hepatic encephalopathy. Nat Rev Dis Primers 8(1):43","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"1533_CR6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/hep.22341","volume":"48","author":"P Jepsen","year":"2008","unstructured":"Jepsen P, Vilstrup H, Andersen PK, Lash TL, S\u00f8rensen HT (2008) Comorbidity and survival of Danish cirrhosis patients: a nationwide population-based cohort study. Hepatology 48(1):214\u2013220","journal-title":"Hepatology"},{"issue":"5","key":"1533_CR7","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/hep.23500","volume":"51","author":"P Jepsen","year":"2010","unstructured":"Jepsen P, Ott P, Andersen PK, S\u00f8rensen HT, Vilstrup H (2010) Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology 51(5):1675\u20131682","journal-title":"Hepatology"},{"unstructured":"Kaplan A (2021) Why do we use lactulose and rifaximin for hepatic encephalopathy? https:\/\/www.aasld.org\/liver-fellow-network\/core-series\/why-series\/why-do-we-use-lactulose-and-rifaximin-hepatic","key":"1533_CR8"},{"issue":"Suppl 8","key":"1533_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1289\/ehp.94102s847","volume":"8","author":"B Langholz","year":"1994","unstructured":"Langholz B, Clayton D (1994) Sampling strategies in nested case-control studies. Environ Health Perspect 102 Suppl 8(Suppl 8):47\u201351","journal-title":"Environ Health Perspect 102 Suppl"},{"issue":"12","key":"1533_CR10","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/MEG.0b013e32834d1938","volume":"23","author":"M Luo","year":"2011","unstructured":"Luo M, Li L, Lu CZ, Cao WK (2011) Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis. Eur J Gastroenterol Hepatol 23(12):1250\u20131257","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1533_CR11","doi-asserted-by":"publisher","first-page":"i124","DOI":"10.1136\/bmj.i124","volume":"352","author":"S McPherson","year":"2016","unstructured":"McPherson S, Lucey MR, Moriarty KJ (2016) Decompensated alcohol related liver disease: acute management. BMJ 352:i124","journal-title":"BMJ"},{"issue":"11","key":"1533_CR12","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/ajg.2014.264","volume":"109","author":"KR Patidar","year":"2014","unstructured":"Patidar KR, Thacker LR, Wade JB, Sterling RK, Sanyal AJ, Siddiqui MS, Matherly SC, Stravitz RT, Puri P, Luketic VA, Fuchs M, White MB, Noble NA, Unser AB, Gilles H, Heuman DM, Bajaj JS (2014) Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization. Am J Gastroenterol 109(11):1757\u20131763","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"1533_CR13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1185\/03007995.2015.1021905","volume":"31","author":"FF Poordad","year":"2015","unstructured":"Poordad FF (2015) Presentation and complications associated with cirrhosis of the liver. Curr Med Res Opin 31(5):925\u2013937","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"1533_CR14","first-page":"798","volume":"46","author":"A Potteg\u00e5rd","year":"2017","unstructured":"Potteg\u00e5rd A, Schmidt SAJ, Wallach-Kildemoes H, S\u00f8rensen HT, Hallas J, Schmidt M (2017) Data Resource Profile: the Danish national prescription Registry. Int J Epidemiol 46(3):798\u2013798f","journal-title":"Int J Epidemiol"},{"key":"1533_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.anaerobe.2019.06.002","volume":"59","author":"J Ruszkowski","year":"2019","unstructured":"Ruszkowski J, Witkowski JM (2019) Lactulose: patient- and dose-dependent prebiotic properties in humans. Anaerobe 59:100\u2013106","journal-title":"Anaerobe"},{"key":"1533_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","volume":"7","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, S\u00f8rensen HT (2015) The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 7:449\u2013490","journal-title":"Clin Epidemiol"},{"issue":"2","key":"1533_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/MEG.0000000000000529","volume":"28","author":"DL Shawcross","year":"2016","unstructured":"Shawcross DL, Dunk AA, Jalan R, Kircheis G, de Knegt RJ, Laleman W, Ramage JK, Wedemeyer H, Morgan IE (2016) How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and responsibilities beyond the liver specialist. Eur J Gastroenterol Hepatol 28(2):146\u2013152","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"18","key":"1533_CR18","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2023.5997","volume":"329","author":"EB Tapper","year":"2023","unstructured":"Tapper EB, Parikh ND (2023) Diagnosis and management of cirrhosis and its complications. Rev JAMA 329(18):1589\u20131602","journal-title":"Rev JAMA"},{"issue":"3","key":"1533_CR19","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.cgh.2019.12.017","volume":"19","author":"EB Tapper","year":"2021","unstructured":"Tapper EB, Korovaichuk S, Baki J, Williams S, Nikirk S, Waljee AK, Parikh ND (2021) Identifying patients with hepatic Encephalopathy using Administrative Data in the ICD-10 era. Clin Gastroenterol Hepatol 19(3):604\u2013606e601","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"1533_CR20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.cld.2024.03.008","volume":"28","author":"KL Thomsen","year":"2024","unstructured":"Thomsen KL, S\u00f8rensen M, Kj\u00e6rgaard K, Eriksen PL, Lauridsen MM, Vilstrup H (2024) Cereb aspects portal hypertension: hepatic encephalopathy. Clin Liver Dis 28(3):541\u2013554","journal-title":"Clin Liver Dis"},{"issue":"1","key":"1533_CR21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","volume":"69","author":"M Thursz","year":"2018","unstructured":"Thursz M, Gual A, Lackner C, Mathurin P, Moreno C, Spahr L, Sterneck M, Cortez-Pinto H (2018) EASL Clinical Practice guidelines: management of alcohol-related liver disease. J Hepatol 69(1):154\u2013181","journal-title":"J Hepatol"},{"issue":"8","key":"1533_CR22","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s10654-013-9873-0","volume":"29","author":"LC Thygesen","year":"2014","unstructured":"Thygesen LC, Ersb\u00f8ll AK (2014) When the entire population is the sample: strengths and limitations in register-based epidemiology. Eur J Epidemiol 29(8):551\u2013558","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"1533_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1023\/A:1022835207287","volume":"21","author":"K Vestberg","year":"1997","unstructured":"Vestberg K, Thulstrup AM, S\u00f8rensen HT, Ottesen P, Sabroe S, Vilstrup H (1997) Data quality of administratively collected hospital discharge data for liver cirrhosis epidemiology. J Med Syst 21(1):11\u201320","journal-title":"J Med Syst"},{"issue":"2","key":"1533_CR24","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hep.27210","volume":"60","author":"H Vilstrup","year":"2014","unstructured":"Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, Wong P (2014) Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the study of. Liver Hepatol 60(2):715\u2013735","journal-title":"Liver Hepatol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01533-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-025-01533-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01533-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T05:52:58Z","timestamp":1740549178000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-025-01533-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["1533"],"URL":"https:\/\/doi.org\/10.1007\/s11011-025-01533-w","relation":{},"ISSN":["1573-7365"],"issn-type":[{"type":"electronic","value":"1573-7365"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was based exclusively on data from the Danish national healthcare registries and therefore it did not need permission from an ethics committee according to Danish law.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"No patient consent was not needed for this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}],"article-number":"107"}}